Ceregene is a biopharmaceutical company developing neurotropic growth factor treatments for major neurodegenerative disorders using a proprietary gene delivery technology. Therapies for Parkinson’s disease and Alzheimer’s disease are in clinical development. 
  • Sector: Healthcare
  • Status: Private
  • Geographic Market: U.S.
  • Investment Year: 2007
  • Board Representation: Ashley Friedman
  • Investment Team: Richard Murphey

Visit the company’s website.